Sales & Earnings In Brief
This article was originally published in The Rose Sheet
Sales advanced 5% to $2.7 billion at Estee Lauder in the first fiscal quarter; Revlon posts Q3 profit and adds new CEO. More sales and earnings news in brief.
You may also be interested in...
Thirteen years after selling its professional products business to CVC Capital Partners, Revlon buys it back, now in a position to grow the salon hair- and nail-care brands. The acquisition extends the firm’s reach in markets outside of the U.S. and, according to Kline’s Carrie Mellage, “signals Revlon’s return as a serious contender in the personal-care industry.”
The company maintains that its products are safe, but plaintiffs in proposed class actions allege it has knowingly put consumers at risk of hair loss and other injuries. DevaCurl’s troubles escalated quickly after a former brand ambassador went viral with a 31 January video urging consumers to stop using DevaCurl products and adopt safer alternatives.
To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.